🟢 HCW Biologics is trading 5.3% up today on continued insider-buying momentum

HCW Biologics is trading at $3.79 (5.3% up) in pre-market, extending a strong multi-day rally that began in late July.

• Recent gains are driven by sustained market enthusiasm following CEO Hing Wong’s insider share purchases disclosed on July 29.
• The insider activity has kept traders focused on the name, supporting continued follow-through buying into the early session.